Skip to main content
Premium Trial:

Request an Annual Quote

This Week in the British Medical Journal: Jun 20, 2011

Premium

In the British Medical Journal this week, readers respond to a study that appeared in the journal in March, which suggested that there is no difference in outcome for men who are regularly screened for prostate cancer versus those who are not. Dutch urologist Fritz Schroder writes in a letter that the study had "major shortcomings." Among them, he says, the group of men randomized to screening was very small, and of the 85 prostate cancers diagnosed in screening, 42 were detected as interval cancers, which implies "ineffective screening" during the first two screening rounds. The study's authors respond, saying that although the number of men in the screening group is much smaller than other studies, the long follow-up — 20 years — gives the study statistical power. In addition, the authors write, although the many interval cancers had a large impact on the outcome of the study, screening methods today are much more effective than they were when the study was conducted.

In another letter, the University of Massachusetts Medical School's Jesse Aronowitz questions the study's conclusion that screening offers little benefit. A quarter of the men randomized to the screening cohort didn't attend and two thirds of the attendees weren't invited for a second prostate specific antigen determination because of their age, and Aronowitz questions whether a single PSA test be considered a screening program. Also, only a quarter of the men diagnosed with prostate cancer in the screening cohort were treated with "curative intent," and about half of the men in the entire study died of their disease. "An equally valid reason for the dismal prostate cancer survival among these men is that they were underscreened and undertreated," he adds. The study's authors reply that most of the men attended at least two screening rounds and that the high mortality in the screening group is probably explained by the low percentage of men undergoing "radical treatment."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.